RecruitingPhase 3NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Cleveland, OH · Columbus, OH · Dayton, OH · +99 more sites